Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
GlaxoSmithKline said on Friday European regulators had given the green light to its once-weekly diabetes drug albiglutide, which it is marketing as Eperzan.
Albiglutide belongs to the same class of injectable GLP-1 drugs as Victoza, from Novo Nordisk, and Byetta and Bydureon, from Bristol-Myers Squibb and AstraZeneca.
http://uk.reuters.com/article/2014/01/24/us-gsk-diabetes-idUKBREA0N0NB20140124
Albiglutide belongs to the same class of injectable GLP-1 drugs as Victoza, from Novo Nordisk, and Byetta and Bydureon, from Bristol-Myers Squibb and AstraZeneca.
http://uk.reuters.com/article/2014/01/24/us-gsk-diabetes-idUKBREA0N0NB20140124